CINECA IRIS Institutional Research Information System

CANOSA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.031
EU - Europa 3.779
AS - Asia 2.062
SA - Sud America 66
OC - Oceania 40
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.002
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.943
IT - Italia 1.485
CN - Cina 856
SG - Singapore 493
IE - Irlanda 456
SE - Svezia 347
AT - Austria 248
FR - Francia 245
KR - Corea 244
DE - Germania 213
FI - Finlandia 185
GB - Regno Unito 132
IN - India 111
JP - Giappone 100
VN - Vietnam 92
CA - Canada 79
UA - Ucraina 77
ES - Italia 67
NL - Olanda 56
PL - Polonia 55
BE - Belgio 52
ID - Indonesia 43
BR - Brasile 36
AU - Australia 33
UZ - Uzbekistan 28
GR - Grecia 27
TR - Turchia 26
HK - Hong Kong 25
RU - Federazione Russa 21
CH - Svizzera 15
PT - Portogallo 14
CZ - Repubblica Ceca 13
DK - Danimarca 12
RO - Romania 11
CO - Colombia 10
IL - Israele 10
TW - Taiwan 10
BG - Bulgaria 9
MX - Messico 8
CL - Cile 7
EU - Europa 7
HR - Croazia 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
PH - Filippine 6
BY - Bielorussia 5
BA - Bosnia-Erzegovina 4
EG - Egitto 4
NO - Norvegia 4
PE - Perù 4
SN - Senegal 4
UY - Uruguay 4
AR - Argentina 3
IQ - Iraq 3
IR - Iran 3
MK - Macedonia 3
TH - Thailandia 3
ZA - Sudafrica 3
KZ - Kazakistan 2
MT - Malta 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
IM - Isola di Man 1
IS - Islanda 1
LB - Libano 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TG - Togo 1
Totale 11.002
Salva come PNG Salva come JPEG
Città #
Chandler 824
Dublin 444
Singapore 405
Beijing 355
Torino 293
Ashburn 245
Vienna 243
Fairfield 232
Houston 160
Santa Clara 153
Turin 152
Nyköping 148
Wilmington 145
Ann Arbor 136
Columbus 121
Princeton 118
Medford 116
Seattle 116
Villeurbanne 114
Jacksonville 110
Woodbridge 106
Milan 104
Cambridge 87
Redwood City 83
Lappeenranta 69
Fremont 58
Dearborn 55
Dong Ket 54
Warsaw 51
Guangzhou 48
Boston 46
Pisa 45
Jakarta 43
Rome 43
Munich 39
Hangzhou 35
Chengdu 33
Brussels 32
Boardman 30
Paris 29
Shanghai 29
Toronto 29
New York 28
Nanjing 26
Tokyo 24
Mumbai 21
Helsinki 19
Washington 19
Bologna 18
Chicago 18
Seoul 18
Cervignano Del Friuli 17
Los Angeles 17
San Diego 17
Falls Church 16
Hebei 16
Ottawa 16
Padova 16
Palermo 16
Norwalk 15
London 13
Genoa 12
Hong Kong 12
Moncalieri 12
Sydney 12
Amsterdam 11
Hefei 11
Istanbul 10
Madrid 10
Mountain View 10
Pune 10
San Mauro Torinese 10
Stockholm 10
Wuhan 10
Duncan 9
Genova 9
Guiyang 9
Kunming 9
Bengaluru 8
Buffalo 8
Cagliari 8
Dronten 8
Florence 8
Nanchang 8
New Delhi 8
Phoenix 8
Queens 8
Silver Spring 8
São Paulo 8
Atlanta 7
Bethesda 7
Budapest 7
Changsha 7
Detroit 7
Edinburgh 7
Grugliasco 7
Parma 7
Siena 7
Sofia 7
Xian 7
Totale 6.469
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 621
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 388
Acoustic reflex patterns in amyotrophic lateral sclerosis 300
Validation of the revised classification of cognitive and behavioural impairment in ALS 265
Validation of the Italian version of self-administered ALSFRS-R scale 259
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 238
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 221
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 215
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 214
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 197
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 194
18 F-FDG-PET correlates of cognitive impairment in ALS 193
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 186
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 173
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 170
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 156
The multistep hypothesis of ALS revisited: The role of genetic mutations 154
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 150
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 140
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 139
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 134
Influence of cigarette smoking on ALS outcome: A population-based study 134
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 130
Expression of NOX2 protein in neutrophils of patients with ALS 124
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 120
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 120
Cognitive impairment across ALS clinical stages in a population-based cohort 115
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 112
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 108
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 98
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 96
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 96
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 96
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 96
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 94
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 93
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 92
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 92
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 91
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 91
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 91
Segni e sintomi inusuali o rari in Neurologia 91
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 89
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 88
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 84
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 82
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 78
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 76
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 75
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 75
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 73
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 72
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 71
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 71
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 71
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 69
ALS phenotype is influenced by age, sex, and genetics: A population-based study 69
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 69
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 68
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 68
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability 67
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 67
Genetic architecture of ALS in Sardinia. 65
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 65
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 65
Pain in amyotrophic lateral sclerosis: a population-based controlled study 64
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 64
Monomelic amyotrophy is not always benign: A case report 63
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 62
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 62
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 62
Pain in ALS: a case-control study 61
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 61
What’s ALS? ALS clinical phenotypes in an Italian register 59
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 59
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS 59
GBA variants influence cognitive status in amyotrophic lateral sclerosis 59
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis 58
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 58
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 58
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 58
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 57
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis 57
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 57
Religiousness is positively associated with quality of life of ALS caregivers 55
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 54
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 54
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 53
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 52
Clinical phenotypes in amyotrophic lateral sclerosis: a population-based study in Italy 51
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 48
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 45
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 44
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 44
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 43
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 41
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 41
Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis 40
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 38
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 37
Totale 10.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.987
article - articoli 0
book - libri 0
conference - conferenze 4.427
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.414
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020737 0 0 0 0 40 110 122 96 130 128 55 56
2020/20211.224 79 88 82 59 114 97 88 104 177 111 57 168
2021/20221.602 65 31 80 133 119 75 89 74 83 172 396 285
2022/20232.518 276 242 66 228 224 585 165 162 248 97 133 92
2023/20241.631 188 235 115 114 98 145 119 104 27 176 139 171
2024/20251.357 70 248 158 381 500 0 0 0 0 0 0 0
Totale 11.344